- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07641673
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Non-inflatable Transoral Endoscopic Thyroid Surgery
2026년 6월 7일 업데이트: Yun Wu, The Second Hospital of Anhui Medical University
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Non-inflatable Transoral Endoscopic Thyroid Surgery: A Randomized Controlled Study.
This study intends to implement esketamine-assisted anesthesia in patients undergoing non-inflatable transoral endoscopic thyroidectomy through a prospective randomized controlled trial, in order to observe the effect of esketamine on coughing during extubation in thyroidectomy patients.
연구 개요
상태
아직 모집하지 않음
연구 유형
중재적
등록 (추정된)
186
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
- 이름: Yun Wu
- 전화번호: 8613865958254
- 이메일: wuyunanyi@163.com
연구 장소
-
-
Anhui
-
Hefei, Anhui, 중국
- Second Affiliated Hospital of Anhui Medical University
-
연락하다:
- Yun Wu
- 전화번호: 8613865958254
- 이메일: wuyunanyi@163.com
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
아니
설명
Inclusion Criteria:
- Patients scheduled for endotracheal intubation-free thyroid surgery under oral endoscopy
- ASA class I-II
- Voluntarily participate in the study and sign the informed consent form
Exclusion Criteria:
- Body Mass Index > 30 kg/m²
- Patients with unstable ischemic cardiomyopathy, pulmonary hypertension, poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure >180/100 mmHg)
- Hepatic or renal dysfunction
- History of oral, maxillofacial, neck, or airway surgery, or pathological structural alterations
- Respiratory diseases (COPD, asthma, inflammation, chronic cough)
- Patients with elevated intracranial pressure
- Patients undergoing repeat surgery
- History of allergy to the investigational drug used in the study
- Patients with psychiatric disorders or alcohol abuse (daily ethanol intake ≥40 g, or having experienced alcohol withdrawal within the past 6 months, or unable to control alcohol consumption)
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: ESK iv group
During anesthesia induction, administer esketamine intravenously at 0.5 mg/kg.
Once muscle relaxation is achieved, under direct laryngoscopic visualization, spray physiological saline (3 ml) above the glottis, at the glottis, and below the glottis.
|
During anesthesia induction, administer esketamine intravenously at 0.5 mg/kg.
Once muscle relaxation is achieved, under direct laryngoscopic visualization, spray physiological saline (3 ml) above the glottis, at the glottis, and below the glottis.
|
|
실험적: ESK spray group
During anesthesia induction, intravenously inject an equal amount of normal saline.
Once muscle relaxation is achieved, under direct laryngoscopic visualization, spray esketamine at the supraglottic, glottic, and subglottic levels: 3 ml (0.5 mg/kg).
|
During anesthesia induction, Once muscle relaxation is achieved, under direct laryngoscopic visualization, spray esketamine at the supraglottic, glottic, and subglottic levels: 3 ml (0.5 mg/kg).
|
|
위약 비교기: CON group
During anesthesia induction, intravenous injection of an equal amount of normal saline is administered.
After achieving muscle relaxation, under direct laryngoscopic view, spray normal saline over the supraglottic, glottic, and subglottic areas: 3 ml.
|
During anesthesia induction, intravenous injection of an equal amount of normal saline is administered.
After achieving muscle relaxation, under direct laryngoscopic view, spray normal saline over the supraglottic, glottic, and subglottic areas: 3 ml.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of coughing during tracheal extubation
기간: Perioperative (From the awakening period to immediately after tracheal extubation)
|
0=None; 0 = Did not occur; 1 = Occurred;
|
Perioperative (From the awakening period to immediately after tracheal extubation)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Postoperative analgesic dosage
기간: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Intraoperative doses of propofol
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of remifentanil
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of sufentanil
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative fluid volume
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative blood loss
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Postoperative time to ambulation
기간: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Length of postoperative hospital stay
기간: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Postoperative time to first water intake
기간: Perioperative (Time from returning to the ward to the first drink of water)
|
Perioperative (Time from returning to the ward to the first drink of water)
|
|
|
Severity of coughing during tracheal extubation
기간: Perioperative (From the awakening period to immediately after tracheal extubation)
|
Grade 0: No choking cough; Grade 1: Single cough episode, considered mild choking cough; Grade 2: Intermittent cough, lasting less than 5 seconds, considered moderate choking cough; Grade 3: Continuous severe cough, lasting more than 5 seconds, considered severe choking cough; The higher the degree, the worse it is.
|
Perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Agitation score during tube removal
기간: Perioperative (From the awakening period to immediately after tracheal extubation)
|
1: Awake and calm; 2: Mild agitation but can be comforted; 3: Moderate agitation, difficult to comfort; 4: Severe agitation, cannot be comforted; The higher the degree, the worse the situation.
|
Perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Blood pressure
기간: Perioperative (From the induction period until 5 minutes after the completion of surgery)
|
Baseline , post-induction, 1 minute after intubation, at the end of the surgery, 1 minute after extubation, and 5 minutes after extubation.
|
Perioperative (From the induction period until 5 minutes after the completion of surgery)
|
|
Airway pressure 5 minutes after intubation and at the end of surgery
기간: 5 minutes after intubation and at the end of the surgery.
|
5 minutes after intubation and at the end of the surgery.
|
|
|
Intraoperative use rate and dosage of vasoactive drugs
기간: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Sore throat score
기간: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively.
|
0 = None; 1 = Mild, milder than a common cold; 2 = Moderate, like a sore throat from a common cold; 3 = Severe, more severe than a common cold; The higher the score, the greater the level of pain.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively.
|
|
Surgical area pain scores
기간: Postoperative 24 hours and 48 hours.
|
Pain NRS scale score: 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain; The higher the score, the more severe the pain.
|
Postoperative 24 hours and 48 hours.
|
|
Incidence of adverse reactions
기간: Within 48 hours after surgery
|
Within 48 hours after surgery
|
|
|
Postoperative nausea and vomiting(PONV) score
기간: Within 48 hours after surgery.
|
Vomiting: 0 = None; 1 = Once; 2 = Twice; 3 = Three times or more Nausea, does it affect daily life: 0 = None; 1 = Sometimes; 2 = Often; 3 = Always
|
Within 48 hours after surgery.
|
|
Postoperative time to first food
기간: Perioperative (Time from returning to the ward to the first food)
|
Perioperative (Time from returning to the ward to the first food)
|
|
|
Upper Aerodigestive Symptoms After Thyroidectomy (UADS) questionnaire score
기간: One month after surgery
|
Upper Aerodigestive Symptoms After Thyroidectomy Questionnaire; Instructions: 0=No problem, 1=Minor, 2=Moderate, 3=Major. Voice symptoms
|
One month after surgery
|
|
Heart rate
기간: From the induction period until 5 minutes after the completion of surgery.
|
Baseline, post-induction, 1 minute after intubation, at the end of the surgery, 1 minute after extubation, and 5 minutes after extubation.
|
From the induction period until 5 minutes after the completion of surgery.
|
|
Oxygen saturation
기간: Intraoperative (From the induction period until 5 minutes after the completion of surgery)
|
Baseline , post-induction, 1 minute after intubation, at the end of the surgery, 1 minute after extubation, and 5 minutes after extubation.
|
Intraoperative (From the induction period until 5 minutes after the completion of surgery)
|
|
Anesthesia time
기간: Time from induction to discontinuation of anesthetic agents.
|
Time from induction to discontinuation of anesthetic agents.
|
|
|
Surgery time
기간: From the start of surgery to the end of surgery.
|
From the start of surgery to the end of surgery.
|
|
|
Endotracheal tube indwelling time
기간: Perioperative (Time from intubation to extubation)
|
Perioperative (Time from intubation to extubation)
|
|
|
Awakening time
기간: Perioperative (Stop the anesthesia drug injection until awakening time)
|
Perioperative (Stop the anesthesia drug injection until awakening time)
|
|
|
Extubation time
기간: Perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
Perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
|
|
Post-anesthesia care unit (PACU) stay time
기간: Perioperative (Duration from entering the PACU to leaving the PACU)
|
Perioperative (Duration from entering the PACU to leaving the PACU)
|
|
|
Hoarseness scores
기간: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively.
|
0 = None; 1 = Transient hoarseness occurs; 2 = Patient perceives hoarseness during visit; 3 = Hoarseness is clearly noticeable; The higher the score, the more severe the hoarseness.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively.
|
|
Sleep scores
기간: Postoperative 24 hours and 48 hours.
|
1 = Good sleep; 2 = Restless sleep; 3 = Dreamy sleep; 4 = Insomnia; The higher the score, the poorer the sleep.
|
Postoperative 24 hours and 48 hours.
|
|
Numbness scores
기간: Postoperative 24h and 48h.
|
Numbness Score: 0 = None; 1-3: Mild numbness, occasionally perceived, does not affect daily activities; 4-6: Moderate numbness, persistent numbness with slight discomfort, affecting some eating/speaking; 7-10: Severe numbness, strong numbness or complete loss of sensation, severely affecting daily life.
The higher the score, the greater the level of numbness.
|
Postoperative 24h and 48h.
|
|
PACU RASS score
기간: Perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room)
|
|
Perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room)
|
|
Postoperative analgesic dosage
기간: Within 48 hours after surgery
|
Within 48 hours after surgery
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (추정된)
2026년 6월 1일
기본 완료 (추정된)
2027년 5월 1일
연구 완료 (추정된)
2027년 9월 1일
연구 등록 날짜
최초 제출
2026년 5월 22일
QC 기준을 충족하는 최초 제출
2026년 6월 7일
처음 게시됨 (실제)
2026년 6월 11일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 6월 11일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 6월 7일
마지막으로 확인됨
2026년 5월 1일
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Esketamine(iv)에 대한 임상 시험
-
Celon Pharma SANational Center for Research and Development, Poland완전한
-
Celon Pharma SANational Center for Research and Development, Poland완전한
-
Chinese PLA General HospitalBeijing 302 Hospital아직 모집하지 않음
-
Beijing Tiantan HospitalBeijing Ditan Hospital; The First Hospital of Fangshan District,Beijing; Hengshui People's... 그리고 다른 협력자들모병
-
argenx모병전신 중증 근무력증 | 중증 근무력증 | gMG | 전신성 중증 근무력증(gMG) | MG | AChR-Ab 혈청 양성 전신형 중증 근무력증미국, 폴란드, 벨기에, 스페인, 이탈리아
-
argenx모병전신 중증 근무력증 | 중증 근무력증 | gMG | 전신성 중증 근무력증(gMG) | MG | AChR-Ab 혈청 양성 전신형 중증 근무력증미국, 스페인, 벨기에, 폴란드, 이탈리아
-
argenx모병특발성 혈소판감소성 자반병 | 면역성 혈소판감소성 자반증 | ITP | 면역성 혈소판 감소증(ITP) | 특발성 혈소판감소성 자반병(ITP) | 면역성 혈소판감소성 자반증( ITP ) | ITP - 면역성 혈소판 감소증스페인, 루마니아, 폴란드, 독일, 영국, 이탈리아